CTSH vs IBM: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
IBM is the larger of the two ($217.60B market cap): the incumbent the market prices for continued execution (17.39x forward earnings, beta 0.76). CTSH is the smaller challenger ($26.43B), cheaper on forward earnings (9.42x): more room to run, but more to prove. If you believe IBM earns its premium (17.39x forward earnings, so the market expects more from it), IBM fits. If you believe in paying less for profit, CTSH fits at 9.42x.
CTSH vs IBM: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | CTSH | IBM | What it tells you |
|---|---|---|---|
| Market cap | $26.43B | $217.60B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 9.42 | 17.39 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 10.79 | 19.64 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.83 | 0.76 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 44% of range | 23% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 1.80 | 6.12 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: CTSH is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how CTSH and IBM affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CTSH and IBM share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CTSH and IBM exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Cognizant Technology Solutions (CTSH) do?
Cognizant Technology Solutions is one of the largest global IT services and consulting firms, with roughly 359,900 employees and a delivery model centered on India-based talent serving mostly North American and European clients. It builds, runs, and modernizes software and business processes across four segments, Health Sciences, Financial Services, Products and Resources, and Communications, Media and Technology, and is increasingly positioning around generative AI, cloud migration, and data services (including a roughly $600 million acquisition of AI-infrastructure provider Astreya).
What does International Business Machines (IBM) do?
International Business Machines (IBM) is one of the oldest and largest technology companies, now focused on enterprise software, consulting, and infrastructure. Its strategy centers on hybrid cloud and AI, anchored by Red Hat (the open-source software it acquired) and its watsonx AI platform. IBM's Software segment sells automation, data, security, and hybrid-cloud software, increasingly on a recurring subscription basis. Consulting provides large-scale technology and business services, helping enterprises modernize and adopt AI. Infrastructure includes IBM's mainframe systems (the zSystems that run mission-critical workloads for banks and large enterprises) and related storage. IBM makes money from a mix of recurring software, services contracts, and hardware tied to mainframe cycles. After years of slow growth, IBM has repositioned around hybrid cloud and AI, divested legacy businesses (spinning off Kyndryl), and emphasized recurring revenue and free cash flow. Founded in 1911 and headquartered in Armonk, New York, IBM is a mature, dividend-paying enterprise technology company. Revenue reached about $67.5 billion in 2025 and about $69.9 billion over the twelve months to September 2026, with net income of about $11.2 billion and free cash flow of about $12.4 billion. In the September 2026 quarter, reported October 21, IBM posted revenue of about $17.1 billion, up 4.7% and ahead of the roughly $16.9 billion consensus, and adjusted EPS of $2.95, up 11% and above the roughly $2.87 estimate. Software revenue rose about 8% to $7.8 billion, with software annual recurring revenue of about $24.9 billion and Red Hat OpenShift ARR above $2.4 billion, up more than 30%, while Consulting was nearly flat at about $5.3 billion and IBM Z mainframe revenue fell 19% at constant currency against a tough prior-year comparison. Management reaffirmed 4% to 5% constant-currency revenue growth for 2026 and raised its free cash flow outlook to growth of more than $1 billion over 2025. The shares still fell about 11% in the month after the report and were down about 21% in 2026 as of November 20.
CTSH vs IBM: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- CTSH drivers: AI-led services and deal momentum; Margin expansion via Project Leap.
- IBM drivers: Hybrid cloud with Red Hat; Enterprise AI with watsonx.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The core risk is that AI automation erodes the labor-arbitrage economics of traditional IT services, pressuring pricing and headcount-linked revenue over time. For IBM, iBM is a mature company that has struggled to grow revenue much above low single digits, so the story depends on the higher-growth software and AI mix offsetting slower legacy areas.
CTSH or IBM: which should you pick?
If the story you believe is CTSH's (AI-led services and deal momentum), CTSH is the more direct way to own it; if it is IBM's (Hybrid cloud with Red Hat), IBM is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CTSH and IBM guides.
CTSH vs IBM: the full fundamentals
CTSH. CTSH's valuation is low for a profitable large-cap, and it fell further after the third-quarter report: at $59.21 on November 20, 2026 the shares trade near 11x trailing earnings and 6.3x EV to EBITDA, about 27% below where they began the year, because the market is skeptical about IT-services growth in an AI world. The 25 covering analysts carry an average target near $69.42, though November brought cuts from Deutsche Bank (to $66) and BofA (to $70). Fourth-quarter consensus is about $1.51 of EPS on roughly $5.55 billion of revenue, with results expected in early 2027; figures change with each quarterly report and share-price move.
IBM. As of November 20, 2026, IBM trades at about 20x trailing and 17x forward earnings, cheaper than in October after an 11% drop following a third quarter that beat estimates, with a dividend yield near 3% and trailing free cash flow of about $12.4 billion. Analysts expect EPS of about $12.42 for 2026 and $13.24 for 2027, and twenty-three of them carry an average target near $260. Fourth-quarter results are expected around January 27, 2027, with consensus near $4.63 of EPS on about $20.4 billion of revenue.
Headline figures (approximate, November 2026): CTSH shows revenue (ttm) ~$21.9B, Q3 2026 growth ~+4.6% YoY, q3 2026 results revenue ~$5.66B; adjusted EPS ~$1.49 vs ~$1.46 consensus, net income (ttm) ~$2.6B, ~11.8% net margin, operating margin (ttm) ~16.3%; IBM shows revenue (ttm) ~$69.9 billion, revenue growth (q3 2026, yoy) ~4.7%; 2026 guidance 4-5% at constant currency, operating margin ~18.4%, net income (ttm) ~$11.2 billion.
The bottom line: CTSH vs IBM
CTSH and IBM are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined CTSH and IBM exposure against your real portfolio. It is not an investment adviser.
Wondering how CTSH or IBM fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Cognizant Technology Solutions
Ask Walnut's AI anything about CTSH and see how it fits what you own.
FAQ
What is the difference between CTSH and IBM?
+
Cognizant Technology Solutions is one of the largest global IT services and consulting firms, with roughly 359,900 employees and a delivery model centered on India-based talent serving mostly North American and European clients. International Business Machines (IBM) is one of the oldest and largest technology companies, now focused on enterprise software, consulting, and infrastructure. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is CTSH or IBM the better stock?
+
Neither is universally better. IBM is the larger incumbent; CTSH is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, CTSH or IBM?
+
On forward P/E (as of November 2026), CTSH trades at 9.42x and IBM at 17.39x, so CTSH is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both CTSH and IBM?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of CTSH vs IBM?
+
CTSH: The core risk is that AI automation erodes the labor-arbitrage economics of traditional IT services, pressuring pricing and headcount-linked revenue over time. Near-term demand is soft: clients are cutting discretionary spending, delaying projects, and focusing on cost, and revenue growth has stayed around 4.5% to 4.6% year over year in the second and third quarters of 2026, with Deutsche Bank projecting organic growth near 2% by year end. Cognizant also faces intense competition and pricing pressure from larger peer Accenture and India-based rivals such as TCS, Infosys, Wipro, and HCL. Client concentration in banking, financial services, and health sciences means a downturn in those verticals hits results, and a large share of delivery in India exposes the company to wage inflation, currency swings, immigration/visa policy, and geopolitical risk. Execution on Project Leap and integrating acquisitions add further uncertainty. Immigration policy became a live issue again in October 2026, with headlines on a US suspension affecting the employer-sponsored green-card (PERM) process, a pressure point for any firm that relies on India-based talent working onsite in the US. Sentiment turned again after the October 29 report: the shares fell about 16% over the month to November 20, 2026 as Deutsche Bank downgraded to Hold ($66 target) and BofA cut its target to $70 from $91, and a narrowed 2026 outlook leaves little room for a weak fourth quarter. IBM: IBM is a mature company that has struggled to grow revenue much above low single digits, so the story depends on the higher-growth software and AI mix offsetting slower legacy areas. Consulting is cyclical and sensitive to enterprise IT budgets. IBM competes against larger, faster-growing cloud and software rivals like Microsoft, Amazon, and Google, and its public-cloud presence is small. The Red Hat acquisition added debt, and total debt stood near $63.8 billion (including $12.7 billion tied to IBM Financing) against about $11.1 billion of cash and marketable securities at September 30, 2026, and large past acquisitions carry integration and goodwill risk. Mainframe revenue is lumpy, tied to product cycles, and fell 19% at constant currency in the third quarter of 2026. Consulting signings slipped 2% at constant currency in that quarter, and Zacks reported that analyst estimates had been trending downward in the month after the report. Realizing the AI opportunity at scale is uncertain, and the stock's appeal rests heavily on cash flow and the dividend rather than rapid growth. The stock has also been volatile for a mature name: it traded between about $199 and $332 over the past year and was down about 21% year to date and over one year, and about 9% over one month, as of November 20, 2026, so sentiment toward its software and AI story can shift quickly.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CTSH or IBM; figures are approximate and dated (as of November 2026). Verify current data before investing.